Corporate Banner
Satellite Banner
Technology Networks Header
Thursday, October 23, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
XEI Scientific Awarded Patent for New TEM Stage Loader
Wednesday, May 21, 2014
Company has been granted a new US patent # US8716676B2 on May 6, 2014.

Bio-Rad Expands Portfolio of PrimePCR™ Assays for Droplet Digital™ PCR
Wednesday, May 21, 2014
Company expands its collection of validated assays for mutation detection and copy number variation.

A 30 Year Partnership with Agar Scientific
Friday, May 16, 2014
Long-standing relationship helps Dr Young throughout a research career spanning rheumatoid arthritis, ocular degeneration.

Malvern Publishes New Whitepaper that Explores AQbD
Friday, May 16, 2014
The whitepaper is freely available for download from http://www.malvern.com/beyond_sops.

Aptiv Solutions Improves Accuracy of Dose Escalation Studies with Launch of ADDPLAN® DF 3.0
Friday, May 16, 2014
ADDPLAN® DF 3.0 incorporates complex statistical methodologies to prevent under and over-estimation of a therapeutic’s maximum target dose (MTD) during Phase I dose escalation trials.

Introduction to Solid State ChIP Technology
Thursday, May 15, 2014
New video from Porvair gives live demonstration of the Chromatin Immunoprecipitation assay.

Shimadzu Introduces C2P Automated Purification/Powderization System
Thursday, May 15, 2014
Crude2Pure for improved purity, efficiency and productivity.

ELGA LabWater PURELAB® Chorus Scoops Gold at the A’ Design Awards
Thursday, May 15, 2014
ELGA LabWater wins design award for empowering users of new PURELAB Chorus systems.

Hologic’s New Tomcat Pre-analytical Sample Processing Instrument to be Featured at ASM2014
Thursday, May 15, 2014
The instrument streamlines laboratory workflow by providing automated processing of liquid-based cytology samples.

<< 7 8 9 10 11 12 13 >>
Showing Results 91 - 100 of 2588
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv